Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Integrated genomic and immunophenotypic profiling of histiocytic disorders reveals therapeutic implications of differential BCL2 expression

Hind Salama, Yasir M. Alsubhi, Mohammed Omer, Saeed Alshieban, Danah Awwadh AlHarthi, Tahani M. AlHalouly, Mohsen Alzahrani, Mohammad Alkaiyat, Ibraheem Motabi

Blood (2025) 146 (Supplement 1): 2986.

https://doi.org/10.1182/blood-2025-2986

Published: 2025

Journal Articles

Outcomes of standard versus reduced-doses post-transplant cyclophosphamide prophylaxis in matched sibling donor allogeneic hematopoietic cell transplant: A retrospective study at a single tertiary center in Saudi Arabia

Alaa Eldein Yahia, Abdullah Alsakkaf, Abdulaziz Aldarami, Yazeed A. Aljudaya, Hallal B. AlOtaibi, Bilal Albtoosh, Jude Howaidi, Gamal Mohamed, Mohammed Alwadi, Mohammed S Alnoamani, Kamal Alzahrani, Imran Tailor, Nawal Alshehry, Muhanad Alhumaied, Ibraheem Motabi, Mohammed Marei, Hassan Alshehri

Blood (2025) 146 (Supplement 1): 7721.

https://doi.org/10.1182/blood-2025-7721

Published: 2025

Journal Articles

A real-world experience of axicabtagene ciloleucel CAR-T in refractory/relapsed B-cell lymphoma from a tertiary center in Saudi Arabia

Alaa Eldein Yahia, Bilal Albtoosh, Abdullah Alsakkaf, Khaled M Alsubiaee, Abdullah M. Alrajhi, Gamal Mohamed, Mohammed Alwadi, Kamal Alzahrani, Mohammed S Alnoamani, Hassan Alshehri, Muhned Alhumaid, Nawal Alshehry, Ibraheem Motabi, Mohammed Marei, Imran Tailor

Blood (2025) 146 (Supplement 1): 7236.

https://doi.org/10.1182/blood-2025-7236

Published: 2025

Journal Articles

Real-world outcomes of HIV-associated lymphomas: A retrospective study at a single tertiary center in Saudi Arabia

Abdullah Alsakkaf, Alaa Eldein Yahia, Amjad Alamar, Refan Alwabel, Bilal Albtoosh, Kamal Alzahrani, Mohammed Alwadi, Mohammed S Alnoamani, Nawal Alshehry, Hassan Alshehri, Hussam Alobida, Muhned Alhumaid, Ibraheem Motabi, Mohammed Marei, Imran Tailor

Blood (2025) 146 (Supplement 1): 8100.

https://doi.org/10.1182/blood-2025-8100

Published: 2025

Journal Articles

Upfront Alternative Donor Transplant Versus Immunosuppressive Therapy in Patients with Severe Aplastic Anemia Who Lack Fully HLA Matched Related Donor: Systematic Review and Meta-Analysis of Retrospective Studies. on Behalf of the Severe Aplastic Anemia Working Party of European Group for Blood and Marrow Transplantation (SAAWP of EBMT)

Hind Alotaibi, MBBS, Mahmoud Aljurf, Regis Peffault De Latour, MD PhD, Shahid Iqbal, Andrea Bacigalupo, Judith Marsh, Hubert Schrezenmeier, Eliane Gluckman, Mansour Alfayez, Britta Hoechsmann, Constantijn Halkes, Josu de la Fuente, Nawal AlShehry, Simone Cesaro, Jakob Passweg, Carlo Dufour, Antonio Risitano, John F. DiPersio, MD PhD, Ibraheem Motabi

Blood (2020) 136 (Supplement 1): 6–7.

https://doi.org/10.1182/blood-2020-140846

Published: 2020

Journal Articles

Outcomes of GCSF and Pre-Emptive Plerixafor Based Peripheral Blood Stem Cell Mobilization Among Patients with Multiple Myeloma-Experience from Newly Established Transplant Unit in Eastern Mediterranean Area

Imran K Tailor, MBBS, MD FRCP, FRCPath, Nawal AlShehry, Nurah F Alenezi, Belal Albtoosh, BSc, RN, Ammar H. Alsughayir, MD, Mohammed Marei, MD, Syed Y Altaf, MD, Syed Ziauddin A Zaidi, FRCP,FRCPath,MBBS, Imran A Pukhta, MD, Rabab Alhazeem, RN, Mansour Alfayez, MDMS, Ibraheem Motabi

Blood (2020) 136 (Supplement 1): 21.

https://doi.org/10.1182/blood-2020-140677

Published: 2020

Journal Articles

Excellent Outcomes of Patients of Middle Eastern Ethnic Origin with Autologous Haemopoietic Stem Cell Transplantation and COVID-19: Does a Dampened Immune System Protect Against Severe COVID-19?

Imran K Tailor, MBBS, MD FRCP, FRCPath, Syed Y Altaf, MD, Nawal F Alshehry, MD, Alaa M Alser, MDMRCP, Mohammed Marei, MD, Mansour Alfayez, MDMS, Ibraheem Motabi, Syed Ziauddin A Zaidi, FRCP,FRCPath,MBBS

Blood (2020) 136 (Supplement 1): 3.

https://doi.org/10.1182/blood-2020-140682

Published: 2020

Journal Articles

Outcomes of Patients of Eastern Mediterranean Region with Lymphoma and COVID-19.Does Recent Chemo Immunotherapy Have a Role on Severity?

Imran K Tailor, MBBS, MD FRCP, FRCPath, Nawal F Alshehry, MD, Kamran Sabir, FCPS, Abdul Rehman Z Zaidi, MBBS, Mohammed Marei, MD, Ibraheem Motabi, Mansour Alfayez, MDMS, Syed Ziauddin A Zaidi, FRCP,FRCPath,MBBS, Syed Y Altaf, MD

Blood (2020) 136 (Supplement 1): 25.

https://doi.org/10.1182/blood-2020-140685

Published: 2020

Update search

NARROW

Publications

Format

Article Type

Date

Availability

Integrated genomic and immunophenotypic profiling of histiocytic disorders reveals therapeutic implications of differential BCL2 expression

Outcomes of standard versus reduced-doses post-transplant cyclophosphamide prophylaxis in matched sibling donor allogeneic hematopoietic cell transplant: A retrospective study at a single tertiary center in Saudi Arabia

A real-world experience of axicabtagene ciloleucel CAR-T in refractory/relapsed B-cell lymphoma from a tertiary center in Saudi Arabia

Real-world outcomes of HIV-associated lymphomas: A retrospective study at a single tertiary center in Saudi Arabia

Outcomes of GCSF and Pre-Emptive Plerixafor Based Peripheral Blood Stem Cell Mobilization Among Patients with Multiple Myeloma-Experience from Newly Established Transplant Unit in Eastern Mediterranean Area

Excellent Outcomes of Patients of Middle Eastern Ethnic Origin with Autologous Haemopoietic Stem Cell Transplantation and COVID-19: Does a Dampened Immune System Protect Against Severe COVID-19?

Outcomes of Patients of Eastern Mediterranean Region with Lymphoma and COVID-19.Does Recent Chemo Immunotherapy Have a Role on Severity?

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only